View Item 

Show simple item record

A Surgical Wound Infection Due to Mycobacterium chelonae Successfully Treated with Clarithromycin
dc.contributor.authorSaluja, Anitaen_US
dc.contributor.authorPeters, Niell T.en_US
dc.contributor.authorLowe, Lorien_US
dc.contributor.authorJohnson, Timothy M.en_US
dc.date.accessioned2013-07-08T17:45:47Z
dc.date.available2013-07-08T17:45:47Z
dc.date.issued1997-07en_US
dc.identifier.citationSaluja, Anita ; Peters, Niell T. ; Lowe, Lori ; Johnson, Timothy M. (1997). "A Surgical Wound Infection Due to Mycobacterium chelonae Successfully Treated with Clarithromycin." Dermatologic Surgery 23(7). <http://hdl.handle.net/2027.42/98824>en_US
dc.identifier.issn1076-0512en_US
dc.identifier.issn1524-4725en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/98824
dc.publisherWiley Periodicals, Inc.en_US
dc.publisherBlackwell Publishing Ltden_US
dc.titleA Surgical Wound Infection Due to Mycobacterium chelonae Successfully Treated with Clarithromycinen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelDermatologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumFrom the University of Michigan Medical Center and Comprehensive Cancer Center (TMJ), Departments of Dermatology (AS, NTP. LL, TMJ), Otolaryngology (TMJ), Surgery (Division of Plastic Surgery) (TMJ), and Pathology (LL), University of Michigan. Ann Arbor, Michigan.en_US
dc.identifier.pmid9236871en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/98824/1/j.1524-4725.1997.tb00681.x.pdf
dc.identifier.doi10.1111/j.1524-4725.1997.tb00681.xen_US
dc.identifier.sourceDermatologic Surgeryen_US
dc.identifier.citedreferenceDautzenberg B, St. Marc T, Meyohas MMC, Eliaszewitch M, Haniez F, Rogues AM, De Wit S, Cotte L, Chauvin JP, Grosset J. Clarithromycin and other antimicrobial agents in the treatment of disseminated Mycobacterium avium infections in patients with acquired immunodeficiency syndrome. Arch Intern Med 1993; 153: 368 – 72.en_US
dc.identifier.citedreferenceLowry PW, Jarvis WR, Oberle AD, Bland LA, Silberman R, Bocchini JA Jr, Dean HD, Swenson JM, Wallace RJ Jr. Mycobacterium chelonae causing otitis media in an ear‐nose‐and‐throat practice. N Engl J Med 1988; 319: 978 – 82.en_US
dc.identifier.citedreferenceWallace RJ Jr, Tanner D, Brennan PI, Brown BA. Clinical trial of Clarithromycin for cutaneous (disseminated) infection due to Mycobacterium chelonae. Ann Intern Med 1993; 119: 482 – 6.en_US
dc.identifier.citedreferenceGrange JM. Mycobacterium chelonei. Tubercle 1981; 62: 273 – 6.en_US
dc.identifier.citedreferenceWallace RJ Jr, Brown BA, Onyi GO. Skin, soft tissue, and bone infections due to Mycobacterium chelonae chelonae: importance of prior corticosteroid therapy, frequency of disseminated infections, and resistance to oral antimicrobials other than Clarithromycin. J Infect Dis 1992; 166: 405 – 12.en_US
dc.identifier.citedreferenceWallace RJ Jr, Swenson JM, Silcox VA, Bullen MG. Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities. J Infect Dis 1985; 152: 500 – 14.en_US
dc.identifier.citedreferenceDalovisio Jr, Pankey GA, Wallace RJ, Jones DB. Clinical usefulness of amikacin and doxycycline in the treatment of infection due to Mycobacterium fortuitum and Mycobacterium chelonei. Rev Infect Dis 1981; 3: 1068 – 74.en_US
dc.identifier.citedreferenceWallace RJ Jr, Jones DB, Wiss K. Sulfonamide activity against Mycobacterium fortuitum and Mycobacterium chelonei. Rev Infect Dis 1981; 3: 898 – 907.en_US
dc.identifier.citedreferenceBrown BA, Wallace RJ Jr, Onyi GO, De Rosas V, Wallace RJ 3d. Activities of four macrolides, including Clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M, chclonae ‐like organisms. Antimicrob Agents Chemother 1992; 36: 180 – 4.en_US
dc.identifier.citedreferenceArley R. Physicians' Desk Reference. Montvale, NJ: Medical Economics Data Products Co., 1996.en_US
dc.identifier.citedreferenceYew WW, Chan CH, Lee J, Leung CW. Cholestatic hepatitis in a patient who received clarithromycin therapy for a Mycobacterium chelonae lung infection (letter). Clin Infect Dis 1994; 18: 1025 – 6.en_US
dc.identifier.citedreferenceFitzgerald DA, Smith AG, Lees A, Yee L, Cooper N, Harris SC, Gibson JA. Cutaneous infections with Mycobacterium abscessus. Br J Dermatol 1995; 132: 800 – 4.en_US
dc.identifier.citedreferenceMushatt DM, Witzig RS. Successful treatment of Mycobacterium abscessus infections with multidrug regimens containing clarithromycin (letter). Clin Infect Dis 1995; 20: 1441 – 2.en_US
dc.identifier.citedreferenceLaing RB, Wynn RF, Leen CL. New antimicrobials against Mycobacterium marinum infection (letter). Br J Dermatol 1994; 131: 914.en_US
dc.identifier.citedreferenceKuhn SM, Rosen W, Wong A, Jadavji T. Treatment of Mycobacterium marinum facial abscess using clarithromycin. Pediatr Infect Dis J 1995; 14: 631 – 2.en_US
dc.identifier.citedreferenceBerlin OGW, Young LS, Floyd‐Reising SA, Bruckner DA. Comparative in vitro activity of the new macrolide A‐56268 against mycobacteria. Eur J Clin Microbiol 1987; 6: 486 – 7.en_US
dc.identifier.citedreferenceFranck N, Cabie A, Villette B, Amor B, Lessana‐Leibowitch M, Escande JP. Treatment of Mycobacterium chelonneinduced skin infection with clarithromycin. J Am Acad Dermatol 1993; 28: 1019 – 21.en_US
dc.identifier.citedreferenceTebas P, Sultan F, Wallace RJ Jr, Fraser V. Rapid development of resistance to clarithromycin following monotherapy for disseminated Mycobacterium chelonae infection in a heart transplant patient. Clin Infect Dis 1995; 20: 443 – 4.en_US
dc.identifier.citedreferenceWallace RJ Jr, Hull SI, Bobey DG, Price KE, Swenson JM, Steele LC, Christensen L. Mutational resistance as the mechanism of acquired drug resistance to aminoglycosides and antibacterial agents in Mycobacterium fortuitum and Mycobacterium chelonei. Evidence is based on plasmid analysis, mutational frequencies, and aminoglycoside‐modifying enzyme assays. Am Rev Respir Dis 1985; 132: 409 – 16.en_US
dc.identifier.citedreferenceWallace RJ Jr, Swensom JM, Silcox VA, Good RC, Tschen JA, Stone MS. Spectrum of disease due to rapidly growing mycobacteria. Rev Infect Dis 1983; 5: 657 – 79.en_US
dc.identifier.citedreferenceHautmann G, Lotti T. Atypical mycobacterial infection of the skin. Derm Clin 1994; 12: 657 – 68.en_US
dc.identifier.citedreferenceZahid MA, Klotz SA, Goldstein E, Bartholomew W. Mycobacterium chelonae ( M. chelonae subspecies chelonae ): report of a patient with a sporotrichoid presentation who was successfully treated with Clarithromycin and ciprofloxacin. Clin Infect Dis 1994; 18: 999 – 1001.en_US
dc.identifier.citedreferenceKelley LC, Deering KC, Kaye ET. Cutaneous Mycobacterium chelonei presenting in an immunocompetent host: case report and review of the literature. Cutis 1995; 56: 293 – 5.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1524-4725.1997.tb00681.x.pdf
Size:
1.898MB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.